Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. logo
ACOR

Acorda Therapeutics, Inc. (ACOR)

$0.5732.53%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.54
Day's Range
$0.5907
$0.2611
52-Week Range
$2.79
1 month return9.42%
3 month return52.84%
1 year return78.86%
5 year return99.54%

Company Information

Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders. INBRIJA® (levodopa inhalation powder) is approved for intermittent treatment of OFF episodes in adults with Parkinson's disease treated with carbidopa/levodopa. INBRIJA is not to be used by patients who take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last two weeks. INBRIJA utilizes Acorda's innovative ARCUS® pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Acorda also markets the branded AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.
OrganizationAcorda Therapeutics, Inc.
Employees118
CEODr. Ron Cohen M.D.
IndustryHealth Technology

Analyst Recommendation

based on 1 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 1 Wall street analysts offering stock ratings for Acorda Therapeutics, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 1645.2%

Current

$0.57

Target

$10.0

Recommendation Trend

Based on 1 analyst

Current1M Ago3M Ago
Buy
1
6
6
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
14.3M
Book Value
$3.11
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-8.22
PEG Ratio
0.51
Wall Street Target Price
10.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.2
Enterprise Value
187.9M
Enterprise Value/Revenue
1.51
Enterprise Value/Ebitda
-14.87

Technicals

Beta
1.56
50 Day MA
0.55
200 Day MA
0.83

Institutional Holdings

Davidson Kempner Capital Management LP

9.84%

Canyon Capital Advisors LLC

4.91%

Renaissance Technologies Corp

3.7%

Millennium Management LLC

1.28%

Vanguard Group Inc

0.64%

Virtu Financial LLC

0.6%

Discover more

Frequently Asked Questions

What is Acorda Therapeutics, Inc. share price today?

Can Indians buy Acorda Therapeutics, Inc. shares?

How can I buy Acorda Therapeutics, Inc. shares from India?

Can Fractional shares of Acorda Therapeutics, Inc. be purchased?

What are the documents required to start investing in Acorda Therapeutics, Inc. stocks?

What are today’s High and Low prices of Acorda Therapeutics, Inc.?

What are today’s traded volumes of Acorda Therapeutics, Inc.?

What is today’s market capitalisation of Acorda Therapeutics, Inc.?

What is the 52 Week High and Low Range of Acorda Therapeutics, Inc.?

How much percentage Acorda Therapeutics, Inc. is down from its 52 Week High?

How much percentage Acorda Therapeutics, Inc. is up from its 52 Week low?

What are the historical returns of Acorda Therapeutics, Inc.?

Who is the Chief Executive Officer (CEO) of Acorda Therapeutics, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*